GSHD
Goosehead Insurance, Inc
GSHD's fundamentals are strong and it looks cheap: trading at 33x earnings, less than half its usual 191x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
GSHD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
GSHD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like GSHD.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
GSHD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $45.66 | — |
| Current | 33x | $45.66 | — |
| Cheap | 70x | $95.30 | +109% |
| Fair | 187x | $256 | +461% |
| Expensive | 400x | $548 | +1100% |
Historical ranges are pointers, not guarantees.
GSHD's PE is in its cheap range at 33x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
GSHD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
GSHD has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
GSHD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.35 | +71% |
| Q2 2026 | $1.37 | +20% |
| Q1 2026 | $1.14 | -5% |
| Q4 2025 | $1.04 | -10% |
| Q3 2025 | $1.14 | +63% |
| Q2 2025 | $1.14 | +65% |
| Q1 2025 | $1.20 | +100% |
| Q4 2024 | $1.16 | +111% |
| Q3 2024 | $0.70 | +52% |
GSHD has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
GSHD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $113.4M | +21% |
| Q1 2026 | $93.1M | +23% |
| Q4 2025 | $105.3M | +12% |
| Q3 2025 | $90.4M | +16% |
| Q2 2025 | $94M | +20% |
| Q1 2025 | $75.6M | +17% |
| Q4 2024 | $93.9M | +49% |
| Q3 2024 | $78M | +9.9% |
GSHD's revenue has grown year over year every quarter since late 2020: $113M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 23% | +6.8 points |
| Q1 2026 | 16% | +7.4 points |
| Q4 2025 | 29% | -0.3 points |
| Q3 2025 | 24% | +2.5 points |
| Q2 2025 | 17% | -3.1 points |
| Q1 2025 | 8.8% | +6.5 points |
| Q4 2024 | 30% | +19 points |
| Q3 2024 | 21% | +1.9 points |
GSHD has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
GSHD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $14.4M | -47% |
| Q1 2026 | $21.2M | +42% |
| Q4 2025 | $20.3M | +68% |
| Q3 2025 | $23.7M | -15% |
| Q2 2025 | $27.2M | +44% |
| Q1 2025 | $14.9M | +28% |
| Q4 2024 | $12.1M | -7.3% |
| Q3 2024 | $28M | +35% |
GSHD has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
GSHD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -930K shares |
| 1 year | -7.4% | -2.8M shares |
| 3 years | +54% | +12.5M shares |
| 5 years | +94% | +17.3M shares |
| Available history | +117% | +19.3M shares |
GSHD has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $3.9M |
| Q1 2026 | $49.8M |
| Q4 2025 | $23.5M |
| Q3 2025 | $57.7M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2021 | — |
GSHD spent $135M buying back its own shares over the past year.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
GSHD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 2.9x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | 0.9x | Very low |
GSHD has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
GSHD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 21.4 | Neutral |
GSHD's weekly RSI is 44 (neutral) and its Stochastic is 21 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
GSHD PE vs Financial Services Sector
| Metric | GSHD | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 13x | 156% above |
| PE % | 2 | 63 | 61 pts below |
GSHD is trading at 33x earnings, a 156% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
GSHD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.3 | 3.4% below |
| 20 week MA | $55.6 | 18% below |
| 50 week MA | $53.7 | 15% below |
| 100 week MA | $74.9 | 39% below |
| 200 week MA | $72.9 | 37% below |
GSHD is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over GSHD on trend strength, trading above more of its moving averages.
GSHD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.1 | $124.2 | +195% |
| 2021 | $124.2 | $138.1 | +11% |
| 2022 | $138.1 | $38.3 | -72% |
| 2023 | $38.3 | $75.8 | +98% |
| 2024 | $75.8 | $104.2 | +37% |
| 2025 | $104.2 | $75.3 | -28% |
| 2026 YTD | $75.3 | $45.7 | -39% |
GSHD has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.